Necroptosis is a programmed form of necrosis, and is an alternative mode of regulated cell death mimicking features of apoptosis and necrosis.
Generally, cell demise and its survival are the fundamental features of metazoans to maintain the tissue homeostasis. On morphological basis, cell death is achieved by apoptosis, necrosis, and autophagy.
A plenty of studies has been performed on apoptosis and autophagy and reveals a clear picture of molecular mechanisms of apoptosis and autophagy which is recognized as a highly regulated process. Hence, apoptosis and autophagy are usually regarded as “programmed cell death”, but necrosis is considered as “un-programmed” due to deregulated activity.
Necroptosis is specific to vertebrates and may have originated as an additional defense to pathogens. Necroptosis also acts as an alternative "fail-safe" cell death pathway in cases where cells are unable to undergo apoptosis, such as during viral infection in which apoptosis signaling proteins are blocked by the virus.
Additionally, recent studies implicate it in a variety of disease states. In myocardial infarction and stroke, atherosclerosis, ischemia-reperfusion injury, pancreatitis, inflammatory bowel disease and a number of other clinically common disorders, necroptosis is of central pathophysiological relevance.
Necroptosis is a newly discovered pathway of regulated necrosis. It can be initiated by different stimuli, such as tumor necrosis factor (TNF), TNF-related apoptosis-inducing ligand (TRAIL), Fas ligand (FasL), interferon (IFN), LPS, viral DNA or RNA, DNA-damage agent and requires the kinase activity of receptor-interacting protein 1 (RIPK1) and RIPK3.
RIPK1 has important kinase-dependent and scaffolding functions that inhibit or trigger necroptosis and apoptosis. Its execution involves ROS generation, calcium overload, the opening of the mitochondrial permeability transition pore, mitochondrial fission, inflammatory response and chromatinolysis. Necroptosis participates in many pathogenesis of diseases, including neurological diseases, retinal disorders, acute kidney injury, inflammatory diseases and microbial infections.
|AIFM1||AIFM1 Antibody||AIFM1 Protein||AIFM1 cDNA||AIFM1 ELISA Kit|
|ALOX15||ALOX15 Antibody||ALOX15 Protein||ALOX15 cDNA||ALOX15 ELISA Kit|
|BAX||BAX Antibody||BAX Protein||BAX cDNA||BAX ELISA Kit|
|BCL2||BCL2 Antibody||BCL2 Protein||BCL2 cDNA||BCL2 ELISA Kit|
|BID||BID Antibody||BID Protein||BID cDNA||BID ELISA Kit|
|BIRC2||BIRC2 Antibody||BIRC2 Protein||BIRC2 cDNA||BIRC2 ELISA Kit|
|BIRC3||BIRC3 Antibody||BIRC3 Protein||BIRC3 cDNA||BIRC3 ELISA Kit|
|CAMK2A||CAMK2A Antibody||CAMK2A Protein||CAMK2A cDNA||CAMK2A ELISA Kit|
|CAMK2B||CAMK2B Antibody||CAMK2B Protein||CAMK2B cDNA||CAMK2B ELISA Kit|
|CAMK2D||CAMK2D Antibody||CAMK2D Protein||CAMK2D cDNA||CAMK2D ELISA Kit|
|CAMK2G||CAMK2G Antibody||CAMK2G Protein||CAMK2G cDNA||CAMK2G ELISA Kit|
|CAPN1||CAPN1 Antibody||CAPN1 Protein||CAPN1 cDNA||CAPN1 ELISA Kit|
|CAPN2||CAPN2 Antibody||CAPN2 Protein||CAPN2 cDNA||CAPN2 ELISA Kit|
|CASP1||CASP1 Antibody||CASP1 Protein||CASP1 cDNA||CASP1 ELISA Kit|
|CASP8||CASP8 Antibody||CASP8 Protein||CASP8 cDNA||CASP8 ELISA Kit|
|CFLAR||CFLAR Antibody||CFLAR Protein||CFLAR cDNA||CFLAR ELISA Kit|
|CHMP1A||CHMP1A Antibody||CHMP1A Protein||CHMP1A cDNA||CHMP1A ELISA Kit|
|CHMP1B||CHMP1B Antibody||CHMP1B Protein||CHMP1B cDNA||CHMP1B ELISA Kit|
|CHMP2A||CHMP2A Antibody||CHMP2A Protein||CHMP2A cDNA||CHMP2A ELISA Kit|
|CHMP2B||CHMP2B Antibody||CHMP2B Protein||CHMP2B cDNA||CHMP2B ELISA Kit|